首页 > 最新文献

European Journal of Contraception and Reproductive Health Care最新文献

英文 中文
The criminalisation of women's healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes. 后多布斯时代对女性医疗保健的刑事定罪:反堕胎触发法法规分析。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-17 DOI: 10.1080/13625187.2023.2242546
Kristina Domanski, Michael Allswede

On 24 June 2022, the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health Organisation held that:'The Constitution does not confer a right to abortion; Roe and Casey are overruled; and the authority to regulate abortion is returned to the people and their elected representatives.'Since the ruling, thirteen states have enacted 'trigger laws' that restrict access to abortion except in specified circumstances, such as to save the life of the pregnant patient in a medical emergency. These laws not only inappropriately insert the State into the physician-patient relationship, but create an uncertain practice landscape for physicians by placing them at risk of criminal penalties. We illustrate the complexity of medical decision making for pregnant patients using examples from the case report literature, and discuss how leaving the definition of 'medical emergency' up to courts to decide will create a patchwork of restrictive and permissive standards that criminalises physicians and creates a 'political standard of care' that replaces evidence based medical care.

2022年6月24日,美国最高法院在多布斯诉杰克逊妇女健康组织案中的裁决认为:“宪法没有赋予堕胎权;罗伊和凯西被否决;管理堕胎的权力又回到了人民及其民选代表手中。”自裁决以来,13个州颁布了“触发法”,限制堕胎,除非在特定情况下,例如在医疗紧急情况下挽救孕妇的生命。这些法律不仅不恰当地将国家纳入医患关系,而且使医生面临刑事处罚的风险,从而为他们创造了一个不确定的执业环境。我们通过案例报告文献中的例子说明了孕妇医疗决策的复杂性,并讨论了将“医疗紧急情况”的定义留给法院来决定将如何创建一个拼凑的限制性和许可性标准,将医生定为犯罪,并创建一个“政治护理标准”来取代基于证据的医疗护理。
{"title":"The criminalisation of women's healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes.","authors":"Kristina Domanski,&nbsp;Michael Allswede","doi":"10.1080/13625187.2023.2242546","DOIUrl":"10.1080/13625187.2023.2242546","url":null,"abstract":"<p><p>On 24 June 2022, the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health Organisation held that:'The Constitution does not confer a right to abortion; Roe and Casey are overruled; and the authority to regulate abortion is returned to the people and their elected representatives.'Since the ruling, thirteen states have enacted 'trigger laws' that restrict access to abortion except in specified circumstances, such as to save the life of the pregnant patient in a medical emergency. These laws not only inappropriately insert the State into the physician-patient relationship, but create an uncertain practice landscape for physicians by placing them at risk of criminal penalties. We illustrate the complexity of medical decision making for pregnant patients using examples from the case report literature, and discuss how leaving the definition of 'medical emergency' up to courts to decide will create a patchwork of restrictive and permissive standards that criminalises physicians and creates a 'political standard of care' that replaces evidence based medical care.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10368351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound beyond the patient's wishes requires more consideration. 超出患者意愿的超声波需要更多的考虑。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-10-30 DOI: 10.1080/13625187.2023.2269454
Chenlin Pei, Yuelan Liu, Weishe Zhang, Liangqun Xie, Jingrui Huang
{"title":"Ultrasound beyond the patient's wishes requires more consideration.","authors":"Chenlin Pei, Yuelan Liu, Weishe Zhang, Liangqun Xie, Jingrui Huang","doi":"10.1080/13625187.2023.2269454","DOIUrl":"10.1080/13625187.2023.2269454","url":null,"abstract":"","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preabortion ultrasound - a patient perspective. 预堕胎超声-从患者角度看。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-09-12 DOI: 10.1080/13625187.2023.2249158
Volodymyr Podolskyi, Kristina Gemzell-Danielsson, Lena Marions, Rebecca Gomperts

Purpose: To explore women's perception of the need for an ultrasound scan before medical abortion provided by telemedicine services.

Methods: We have analysed women's requests for medical abortion through the website www.womenonweb.org from the 1st of January 2019 to the 5th of October 2020. Before receiving abortion drugs for self-managed medical abortion, women received online counselling and were asked to complete an online survey on pre-abortion ultrasound scan and the reasons for having or not having one. The initial dataset included 62641 entries from 207 countries. Each entry corresponded to a person's request for medical abortion. Women reported only one or multiple reasons for not having a pre-abortion ultrasound scan.

Results: Among 59648 women requesting a medical abortion, 45653 (76,54%) did not have any pre-abortion ultrasound scan and specified a reason for that. The countries with the highest rates of women not having a pre-abortion ultrasound scan were Thailand, Poland, Northern Ireland, Mexico, South Korea, Japan, Chile, Indonesia, Germany, and Brazil. The main reasons for not having a pre-abortion ultrasound scan were being confident regarding pregnancy length; and thus, no need for a scan stated by 10910/34390 women (31.7%), lack of resources stated by 10589/34390 women (30.8%), and privacy issues stated by 6472/34390 women (18.8%).

Conclusion: Most women opting for medical abortion through telemedicine did not undergo a pre-abortion ultrasound scan. The main reason stated was that women did not find it necessary, lack of resources and privacy issues.

目的:探讨女性对远程医疗服务提供的药物流产前超声扫描需求的看法。方法:我们通过网站www.womenonweb.org分析了2019年1月1日至2020年10月5日期间女性的药物流产请求。在接受堕胎药物进行自我管理的药物流产之前,女性接受了在线咨询,并被要求完成一项关于堕胎前超声扫描的在线调查,以及是否进行超声扫描的原因。最初的数据集包括来自207个国家的62641个条目。每个条目对应一个人的药物流产请求。女性只报告了一个或多个原因没有进行堕胎前超声波扫描。结果:在59648名要求药物流产的女性中,45653人(76.54%)没有进行任何流产前超声扫描,并说明了原因。没有进行堕胎前超声波扫描的女性比例最高的国家是泰国、波兰、北爱尔兰、墨西哥、韩国、日本、智利、印度尼西亚、德国和巴西。没有进行流产前超声扫描的主要原因是对妊娠期长短有信心;因此,10910/34390名妇女(31.7%)表示不需要扫描,10589/33490名妇女(30.8%)表示缺乏资源,6472/3490名妇女(18.8%)表示存在隐私问题。结论:大多数通过远程医疗选择药物流产的妇女没有进行堕胎前超声扫描。所述的主要原因是妇女认为没有必要、缺乏资源和隐私问题。
{"title":"Preabortion ultrasound - a patient perspective.","authors":"Volodymyr Podolskyi,&nbsp;Kristina Gemzell-Danielsson,&nbsp;Lena Marions,&nbsp;Rebecca Gomperts","doi":"10.1080/13625187.2023.2249158","DOIUrl":"10.1080/13625187.2023.2249158","url":null,"abstract":"<p><strong>Purpose: </strong>To explore women's perception of the need for an ultrasound scan before medical abortion provided by telemedicine services.</p><p><strong>Methods: </strong>We have analysed women's requests for medical abortion through the website www.womenonweb.org from the 1st of January 2019 to the 5th of October 2020. Before receiving abortion drugs for self-managed medical abortion, women received online counselling and were asked to complete an online survey on pre-abortion ultrasound scan and the reasons for having or not having one. The initial dataset included 62641 entries from 207 countries. Each entry corresponded to a person's request for medical abortion. Women reported only one or multiple reasons for not having a pre-abortion ultrasound scan.</p><p><strong>Results: </strong>Among 59648 women requesting a medical abortion, 45653 (76,54%) did not have any pre-abortion ultrasound scan and specified a reason for that. The countries with the highest rates of women not having a pre-abortion ultrasound scan were Thailand, Poland, Northern Ireland, Mexico, South Korea, Japan, Chile, Indonesia, Germany, and Brazil. The main reasons for not having a pre-abortion ultrasound scan were being confident regarding pregnancy length; and thus, no need for a scan stated by 10910/34390 women (31.7%), lack of resources stated by 10589/34390 women (30.8%), and privacy issues stated by 6472/34390 women (18.8%).</p><p><strong>Conclusion: </strong>Most women opting for medical abortion through telemedicine did not undergo a pre-abortion ultrasound scan. The main reason stated was that women did not find it necessary, lack of resources and privacy issues.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10564684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The use and access to contraception in Sweden during the COVID-19 pandemic period. 新冠肺炎大流行期间瑞典避孕的使用和获取情况。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-10-30 DOI: 10.1080/13625187.2023.2260516
Niklas Envall, Kristina Gemzell Danielsson, Helena Kopp Kallner

Purpose: Explore perceived access to, the need for, use of, and satisfaction with telemedicine services for contraceptive counselling and prescription-renewal-only during the COVID-19 pandemic, and the impact of the COVID-19 pandemic period on the choice and use of contraceptives.

Materials and methods: Internet-based e-survey of Swedish women of fertile age, 16-49 years.

Results: In total, 1016 participants completed the survey. Most participants (69.7%) rated their access to contraceptive services 'as usual'. Among the remaining participants, a higher proportion rated their access as deteriorated (73.4%) compared to improved (26.6%; p < 0.001). In total, 38.0% reported a need for contraceptive counselling, whereof 14.0% had used telemedicine for counselling and reported high satisfaction. Telemedicine for prescription-renewal-only was used by 15.1% of the total population. Two per cent reported use of another contraceptive than their intended, whereof long-acting reversible contraceptives were the most common intended method. The proportion of current contraceptive users was lower than in 2017 (62.4% vs 71.1%, p < 0.001), and current users of long-acting reversible contraception decreased from 30.6% to 19.3% (p < 0.001).

Conclusions: During the COVID-19 pandemic period, most women found their access to contraceptive services unaffected, but more women felt that it had deteriorated than improved. The use of telemedicine was low, and the use of contraception overall fell. Efforts are needed to raise awareness of available services, and TM-provided interventions for maintained quality of care and informed decision-making remain to be evaluated.SHORT CONDENSATIONThe COVID-19 period imposed a change in contraceptive service provision, and efforts are needed to raise awareness of available services, including telemedicine. Access to all contraceptives, including LARCs, is crucial and telemedicine-provided interventions need evaluation.

目的:探讨新冠肺炎大流行期间获得、需要、使用和满意度远程医疗服务的情况,仅限避孕咨询和处方更新,以及新冠肺炎大流行期间对避孕药具选择和使用的影响。材料和方法:基于互联网的16-49岁瑞典育龄妇女电子调查 年。结果:共有1016名参与者完成了调查。大多数参与者(69.7%)认为他们获得避孕服务的机会“像往常一样”。在其余参与者中,更高比例的人认为他们的访问情况恶化(73.4%),而改善(26.6%;p p p 结论:在新冠肺炎大流行期间,大多数妇女发现她们获得避孕服务的机会没有受到影响,但更多的妇女认为情况恶化而不是改善。远程医疗的使用率较低,避孕药具的使用率总体下降。需要努力提高对现有服务的认识,TM为保持护理质量和知情决策提供的干预措施仍有待评估。短暂冷凝新冠肺炎时期改变了避孕服务的提供,需要努力提高对包括远程医疗在内的可用服务的认识。获得包括LARC在内的所有避孕药具至关重要,远程医疗提供的干预措施需要评估。
{"title":"The use and access to contraception in Sweden during the COVID-19 pandemic period.","authors":"Niklas Envall,&nbsp;Kristina Gemzell Danielsson,&nbsp;Helena Kopp Kallner","doi":"10.1080/13625187.2023.2260516","DOIUrl":"https://doi.org/10.1080/13625187.2023.2260516","url":null,"abstract":"<p><strong>Purpose: </strong>Explore perceived access to, the need for, use of, and satisfaction with telemedicine services for contraceptive counselling and prescription-renewal-only during the COVID-19 pandemic, and the impact of the COVID-19 pandemic period on the choice and use of contraceptives.</p><p><strong>Materials and methods: </strong>Internet-based e-survey of Swedish women of fertile age, 16-49 years.</p><p><strong>Results: </strong>In total, 1016 participants completed the survey. Most participants (69.7%) rated their access to contraceptive services 'as usual'. Among the remaining participants, a higher proportion rated their access as deteriorated (73.4%) compared to improved (26.6%; <i>p</i> < 0.001). In total, 38.0% reported a need for contraceptive counselling, whereof 14.0% had used telemedicine for counselling and reported high satisfaction. Telemedicine for prescription-renewal-only was used by 15.1% of the total population. Two per cent reported use of another contraceptive than their intended, whereof long-acting reversible contraceptives were the most common intended method. The proportion of current contraceptive users was lower than in 2017 (62.4% vs 71.1%, <i>p</i> < 0.001), and current users of long-acting reversible contraception decreased from 30.6% to 19.3% (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>During the COVID-19 pandemic period, most women found their access to contraceptive services unaffected, but more women felt that it had deteriorated than improved. The use of telemedicine was low, and the use of contraception overall fell. Efforts are needed to raise awareness of available services, and TM-provided interventions for maintained quality of care and informed decision-making remain to be evaluated.SHORT CONDENSATIONThe COVID-19 period imposed a change in contraceptive service provision, and efforts are needed to raise awareness of available services, including telemedicine. Access to all contraceptives, including LARCs, is crucial and telemedicine-provided interventions need evaluation.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provision of contraceptives by Brazilian general gynaecologists: a nationwide online survey. 巴西普通妇科医生提供避孕药具:一项全国性在线调查。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-07-28 DOI: 10.1080/13625187.2023.2233649
Mariana R M Canela, Luiz G O Brito, Agnaldo Lopes Silva-Filho, Luis Bahamondes, Cássia R T Juliato

Objective: To assess the provision of contraceptives by Brazilian obstetricians and gynaecologists (Obst/Gyns) during medical consultation and associated factors.

Methods: An anonymous online survey was conducted with Obst/Gyns regarding age, gender, training, method counselling about and provision of long-acting reversible contraception (LARC).

Results: Of 16,000 Obst/Gyns, 610 (3.8%) answered the survey. After multiple regression analysis, female Obst/Gyns (reference) (OR male was 0.53 [95%CI 0.28-0.98], p = 0.044) and Obst/Gyns aged between 20 and 39 were more likely to provide an IUD. For hormonal-IUDs, Obst/Gyns who had had theoretical training in hormonal-IUD insertion (reference no training) (OR = 2.13 [95%CI 1.14-3.99], p = 0.018), those who work in a private facility or public hospital, and those that allowed more time during consultations (reference) (OR short time = 0.33 [95%CI 0.17-0.63], p < 0.001) were more likely to provide them. Obst/Gyns who were hands-on trained were more likely to provide subdermal implant (OR = 2.04 [95%CI 1.45-2.87], p < 0.001).

Conclusions: There is a gap between theoretical and practical training received by this cohort of Obst/Gyns regarding LARCs, mainly contraceptive implants and hormonal-IUDs. The identification of barriers to offering contraceptives is essential to providing client-centred contraceptive care.

目的:评估巴西妇产科医生在医疗咨询期间提供避孕药具的情况及其相关因素。方法:与妇产科进行了一项关于年龄、性别、培训、方法咨询和长效可逆避孕(LARC)的匿名在线调查。结果:在16000名妇产科患者中,610人(3.8%)回答了调查。经多元回归分析,女性产科/妇科(参考)(OR男性为0.53[95%CI 0.28-0.98],p = 0.044),年龄在20至39岁之间的妇产科医生更有可能提供宫内节育器。对于激素型宫内节育器,接受过激素型宫内避孕器插入理论训练(参考无训练)的妇产科医生(OR=2.13[95%CI 1.14-3.9],p = 0.018),在私人机构或公立医院工作的人,以及在咨询期间允许更多时间的人(参考)(or短时间=0.33[95%CI 0.17-0.63],p p 结论:这一组妇产科医生在LARC方面接受的理论和实践培训之间存在差距,主要是避孕植入物和激素宫内节育器。查明提供避孕药具的障碍对于提供以客户为中心的避孕护理至关重要。
{"title":"Provision of contraceptives by Brazilian general gynaecologists: a nationwide online survey.","authors":"Mariana R M Canela,&nbsp;Luiz G O Brito,&nbsp;Agnaldo Lopes Silva-Filho,&nbsp;Luis Bahamondes,&nbsp;Cássia R T Juliato","doi":"10.1080/13625187.2023.2233649","DOIUrl":"10.1080/13625187.2023.2233649","url":null,"abstract":"<p><strong>Objective: </strong>To assess the provision of contraceptives by Brazilian obstetricians and gynaecologists (Obst/Gyns) during medical consultation and associated factors.</p><p><strong>Methods: </strong>An anonymous online survey was conducted with Obst/Gyns regarding age, gender, training, method counselling about and provision of long-acting reversible contraception (LARC).</p><p><strong>Results: </strong>Of 16,000 Obst/Gyns, 610 (3.8%) answered the survey. After multiple regression analysis, female Obst/Gyns (reference) (OR male was 0.53 [95%CI 0.28-0.98], <i>p</i> = 0.044) and Obst/Gyns aged between 20 and 39 were more likely to provide an IUD. For hormonal-IUDs, Obst/Gyns who had had theoretical training in hormonal-IUD insertion (reference no training) (OR = 2.13 [95%CI 1.14-3.99], <i>p</i> = 0.018), those who work in a private facility or public hospital, and those that allowed more time during consultations (reference) (OR short time = 0.33 [95%CI 0.17-0.63], <i>p</i> < 0.001) were more likely to provide them. Obst/Gyns who were hands-on trained were more likely to provide subdermal implant (OR = 2.04 [95%CI 1.45-2.87], <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>There is a gap between theoretical and practical training received by this cohort of Obst/Gyns regarding LARCs, mainly contraceptive implants and hormonal-IUDs. The identification of barriers to offering contraceptives is essential to providing client-centred contraceptive care.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9886715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The contraceptive choice at the time of a surgical and pharmacological abortion: a possible and effective option thanks to a dedicate counselling. 手术和药物流产时的避孕选择:由于专门的咨询,这是一个可能且有效的选择。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-17 DOI: 10.1080/13625187.2023.2245095
Paola Algeri, Laura Colonna, Vanda Savoldi, Laura Imbruglia, Nunzia Mastrocola, Silvia Von Wunster

The percentage of repeat abortion in Italy is about 25%. It is therefore important to implement the strategies that can facilitate the adoption of the most effective contraceptive methods. Long-acting reversible contraceptive methods are currently considered the most effective and with the highest rates of 12-months continuation, with a reported reduction of recurrent abortion. Our study has the aim to evaluate the contraceptive choice of women requesting abortion, when an accurate and dedicate counselling is offered and the availability of a LARC method is given immediately after pregnancy termination, both in case of surgical and medical abortion. LARC methods were chosen both in case of surgical and medical abortion, by an high percentage of patients. We reported no differences between the surgical and pharmacological groups on the choice of LARC and SARC. Our observational study shows the feasibility to perform an accurate, dedicate, and personalised counselling on contraception at time of abortion. This approach has enabled a high number of women to have a LARC method inserted at the time of abortion, as a valid strategy to prevent the risk unplanned pregnancy.

意大利重复堕胎的比例约为25%。因此,重要的是执行能够促进采用最有效避孕方法的战略。长效可逆避孕方法目前被认为是最有效的,持续12个月的比率最高,据报道可减少复发性流产。我们的研究旨在评估要求堕胎的女性的避孕选择,在手术和药物流产的情况下,当提供准确和专门的咨询,并在终止妊娠后立即提供LARC方法时。在手术流产和药物流产的情况下,高比例的患者都选择了LARC方法。我们报告了手术组和药理学组在LARC和SARC的选择上没有差异。我们的观察性研究表明,在堕胎时进行准确、专门和个性化的避孕咨询是可行的。这种方法使大量妇女能够在堕胎时插入LARC方法,作为预防意外怀孕风险的有效策略。
{"title":"The contraceptive choice at the time of a surgical and pharmacological abortion: a possible and effective option thanks to a dedicate counselling.","authors":"Paola Algeri,&nbsp;Laura Colonna,&nbsp;Vanda Savoldi,&nbsp;Laura Imbruglia,&nbsp;Nunzia Mastrocola,&nbsp;Silvia Von Wunster","doi":"10.1080/13625187.2023.2245095","DOIUrl":"10.1080/13625187.2023.2245095","url":null,"abstract":"<p><p>The percentage of repeat abortion in Italy is about 25%. It is therefore important to implement the strategies that can facilitate the adoption of the most effective contraceptive methods. Long-acting reversible contraceptive methods are currently considered the most effective and with the highest rates of 12-months continuation, with a reported reduction of recurrent abortion. Our study has the aim to evaluate the contraceptive choice of women requesting abortion, when an accurate and dedicate counselling is offered and the availability of a LARC method is given immediately after pregnancy termination, both in case of surgical and medical abortion. LARC methods were chosen both in case of surgical and medical abortion, by an high percentage of patients. We reported no differences between the surgical and pharmacological groups on the choice of LARC and SARC. Our observational study shows the feasibility to perform an accurate, dedicate, and personalised counselling on contraception at time of abortion. This approach has enabled a high number of women to have a LARC method inserted at the time of abortion, as a valid strategy to prevent the risk unplanned pregnancy.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10018175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction [Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?]. 回缩声明[宫内节育器插入前的不同镇痛药:有任何疗效证据吗?]。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-29 DOI: 10.1080/13625187.2023.2251829
{"title":"Statement of Retraction [Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?].","authors":"","doi":"10.1080/13625187.2023.2251829","DOIUrl":"10.1080/13625187.2023.2251829","url":null,"abstract":"","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction [Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial]. 回缩声明[仅用于剖宫产妇女插入铜宫内节育器期间缓解疼痛的2%利多卡因阴道原位凝胶:一项随机、双盲安慰剂对照试验]。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-17 DOI: 10.1080/13625187.2023.2243186
{"title":"Statement of Retraction [Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial].","authors":"","doi":"10.1080/13625187.2023.2243186","DOIUrl":"10.1080/13625187.2023.2243186","url":null,"abstract":"","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10069998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction [Effect of a mobile phone-assisted postpartum family planning service on the use of long-acting reversible contraception: a randomised controlled trial]. 撤回声明[手机辅助产后计划生育服务对使用长效可逆避孕的影响:一项随机对照试验]。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-17 DOI: 10.1080/13625187.2023.2243184
{"title":"Statement of Retraction [Effect of a mobile phone-assisted postpartum family planning service on the use of long-acting reversible contraception: a randomised controlled trial].","authors":"","doi":"10.1080/13625187.2023.2243184","DOIUrl":"10.1080/13625187.2023.2243184","url":null,"abstract":"","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10070837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction [Lidocaine gel vs lidocaine spray in reducing pain during insertion of the intrauterine contraceptive device]. 收缩声明[利多卡因凝胶与利多卡因喷雾减轻宫内节育器插入时疼痛]。
IF 1.7 4区 医学 Q2 Medicine Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2208459
{"title":"Statement of Retraction [Lidocaine gel vs lidocaine spray in reducing pain during insertion of the intrauterine contraceptive device].","authors":"","doi":"10.1080/13625187.2023.2208459","DOIUrl":"https://doi.org/10.1080/13625187.2023.2208459","url":null,"abstract":"","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10212484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Contraception and Reproductive Health Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1